Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Transpek Industry Ltd

TRANSPEK
BSE
1,200.00
1.88%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Transpek Industry Ltd

TRANSPEK
BSE
1,200.00
1.88%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
670Cr
Close
Close Price
1,200.00
Industry
Industry
Speciality Chemicals
PE
Price To Earnings
11.49
PS
Price To Sales
1.05
Revenue
Revenue
638Cr
Rev Gr TTM
Revenue Growth TTM
0.86%
PAT Gr TTM
PAT Growth TTM
66.01%
Peer Comparison
How does TRANSPEK stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
TRANSPEK
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
203162121148148152163170165154160158
Growth YoY
Revenue Growth YoY%
42.1-23.3-44.0-24.5-26.9-6.334.514.611.51.6-1.5-6.8
Expenses
ExpensesCr
163140108121129136140146133130134134
Operating Profit
Operating ProfitCr
402313281916232432242725
OPM
OPM%
19.813.911.118.712.710.513.814.119.515.616.615.7
Other Income
Other IncomeCr
512455115581254
Interest Expense
Interest ExpenseCr
643433333222
Depreciation
DepreciationCr
89991112131213121212
PBT
PBTCr
3121620912121425211714
Tax
TaxCr
953632235544
PAT
PATCr
221631469101119161311
Growth YoY
PAT Growth YoY%
97.8-3.4-85.0-43.0-74.8-41.4219.4-24.4241.367.732.41.9
NPM
NPM%
11.09.82.59.53.86.15.96.311.710.17.96.8
EPS
EPS
40.128.45.425.210.116.617.119.134.527.922.619.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
290284317361595566339599827580650638
Growth
Revenue Growth%
7.6-2.011.614.164.6-4.9-40.076.538.0-29.912.1-1.8
Expenses
ExpensesCr
251237264314478448292503680497555530
Operating Profit
Operating ProfitCr
3847534711711847961478295108
OPM
OPM%
13.216.516.613.019.620.813.916.017.814.214.616.9
Other Income
Other IncomeCr
1147101817172818252928
Interest Expense
Interest ExpenseCr
1311912191610111914129
Depreciation
DepreciationCr
989101426293033385050
PBT
PBTCr
27324235101942684113566277
Tax
TaxCr
510129362121929171319
PAT
PATCr
222130266673236583394958
Growth
PAT Growth%
191.6-3.140.9-11.9149.011.0-68.0180.627.6-53.826.419.7
NPM
NPM%
7.67.59.57.311.112.96.910.910.16.77.59.1
EPS
EPS
37.436.251.947.3117.7130.641.7117.1149.469.087.3104.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
666666666666
Reserves
ReservesCr
6985200241306333374479581668740762
Current Liabilities
Current LiabilitiesCr
1067410918315413610616613611312299
Non Current Liabilities
Non Current LiabilitiesCr
484471136133114113114165180133133
Total Liabilities
Total LiabilitiesCr
2292093865665995895997648879661,0011,000
Current Assets
Current AssetsCr
11895119177173159154244234214301290
Non Current Assets
Non Current AssetsCr
111114267389426430446520652752699709
Total Assets
Total AssetsCr
2292093865665995895997648879661,0011,000

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1944477128111354711198135
Investing Cash Flow
Investing Cash FlowCr
14-16-31-103-45-33-17-70-13-32-30
Financing Cash Flow
Financing Cash FlowCr
-33-27-1796-83-77-39-94-64-56
Net Cash Flow
Net Cash FlowCr
01-100015-144348
Free Cash Flow
Free Cash FlowCr
242747-11280742096660116
CFO To PAT
CFO To PAT%
86.0206.2156.827.9194.0151.6148.172.0132.8253.6277.1
CFO To EBITDA
CFO To EBITDA%
49.593.989.215.7109.493.873.149.075.3118.8142.7

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1422333306898396867621,089822994697
Price To Earnings
Price To Earnings
6.611.411.026.112.89.432.716.79.825.814.3
Price To Sales
Price To Sales
0.50.81.01.91.41.22.21.81.01.71.1
Price To Book
Price To Book
1.92.61.62.82.72.02.02.31.41.50.9
EV To EBITDA
EV To EBITDA
5.56.17.618.48.26.518.012.26.413.27.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
49.356.253.146.849.454.052.147.547.050.448.8
OPM
OPM%
13.216.516.613.019.620.813.916.017.814.214.6
NPM
NPM%
7.67.59.57.311.112.96.910.910.16.77.5
ROCE
ROCE%
27.128.818.711.027.925.87.315.318.18.88.7
ROE
ROE%
29.423.414.610.721.121.66.113.514.25.76.5
ROA
ROA%
9.610.27.84.711.012.43.98.69.44.04.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Company Snapshot** - **Name**: Transpek Industry Limited - **Founded**: 1965 (transitioned into chemical manufacturing in 1968) - **Headquarters**: Vadodara, Gujarat, India - **Core Expertise**: Chlorinated and sulphur-based chemistry, specializing in **Acid Chlorides**, **Alkyl Chlorides**, and **Thionyl Chloride** - **Established Recognition**: First company in Asia to produce Thionyl Chloride (1979); pioneer of Chloro Acetyl Chloride in India (1987) --- ### **Operations & Infrastructure** - **Manufacturing Site**: Ekalbara, Gujarat – a 100-acre facility located within a major chemical industrial zone, ~25 km from Vadodara. - **Total Production Capacity**: 66,000 metric tons per annum (MTPA), including captive consumption - **Merchantable Sales Capacity**: ~30,000 MTPA (15,600 MTPA in-house, the rest via job work arrangements) - **Site Features**: - Multipurpose, multi-product plants equipped for advanced chlorination, sulfonation, Friedel-Crafts, and amidation reactions. - Process automation for consistent quality, energy-efficient technologies, and 100% water recycling using harvested rainwater. - In-house ISO tank station managing over 600 ISO tanks with continuous monitoring; compliant with IMDG and IATA standards. - **Strategic Location**: Proximity to major seaports (Nhava Sheva, Mundra, Pipavav, Hazira) and rail connectivity via Vadodara Inland Container Depot (ICD). --- ### **R&D and Innovation** - **DSIR-Recognized R&D Facility**: Dedicated center approved by the Department of Science & Technology, Government of India. - **Technical Scale-Up Capabilities**: Full pipeline from gram-scale labs → kilo labs → pilot plants → commercial production. - **Academic Collaboration**: Approved by **Maharaja Sayajirao University of Vadodara** for Ph.D. research, reinforcing technical credibility and innovation pipeline. - **Development Pipeline (Feb 2023)**: 15–17 new molecules under various stages of R&D, kilo lab testing, or pilot production, with each having an estimated revenue potential of ₹20–30 crores. - **Recent Innovations (2024–25)**: - Commercialized high-value products: Iso Pivaloyl Chloride, Thionyl Chloride, Sulphur Dichloride, 2-Methoxyethyl Chloride, Diethylene Glycol Dichloride. - Developed and validated **three non-acid chloride products** with global customers (2025). - **R&D Focus Areas**: Expansion beyond chlorination chemistry into **nitration**, **organic peroxides**, **photoinitiators**, **battery chemicals**, and **electronics-grade intermediates**. --- ### **Product Portfolio & Applications** - **Core Products**: - Acid Chlorides (e.g., Pivaloyl, Iso Pivaloyl, Acetyl) - Alkyl Chlorides (e.g., 2-Methoxyethyl Chloride, 2-Propoxyethyl Chloride) - Thionyl Chloride, Sulphur Dichloride, Oxalyl Chloride - Custom chlorinated and sulphur-based specialty chemicals - **End-Use Industries**: - **Polymers & Plastics** (largest revenue contributor – >58% in first nine months of FY25) - Pharmaceuticals (domestic focus; export opportunities emerging) - Agrochemicals (limited presence; strategic caution due to pricing pressure) - Cosmetics, Dyes, Pigments, Personal Care, Organic Peroxides - Defense, Aerospace, Battery Chemicals, Electronics (mission-critical applications) --- ### **Global Business & Market Presence** - **Export-Driven Model**: Over **85% of revenue from exports**, up to 87% in FY24 - **International Markets**: Supplies to **15+ countries** across: - North America (USA, Mexico) - Europe (Germany, France, Italy, Belgium, Spain, Switzerland, Turkey) - Asia (Japan, South Korea, China, India) - South America (Brazil) and Eurasia - **Global Customers**: Long-term relationships with major multinational chemical companies; recognized since 1986 as a pioneering Indian chemical exporter. - **Strategic Geographic Expansion**: Recent entry into **Japan, South America, and Eurasia**, with active customer engagements and growing traction. - **Customer-Centric Innovation**: Collaborative product development with clients in US, Europe, and Japan to co-create tailored solutions meeting regulatory and technical requirements. --- ### **Strategic Initiatives & Growth Plan** - **Diversification Strategy**: - Reducing reliance on acid chlorides and concentrated customer segments. - Developing non-chlorination and value-added multi-synthesis products. - Target: **30–35% of business from high-margin products** within 3–4 years. - **Expansion Approach**: - Organic: Greenfield/brownfield site evaluation due to space constraints at current facility (limited by environmental norms). - Inorganic: Actively evaluating acquisitions in complementary chemistry chains; no deals concluded yet due to lack of suitable targets. - Low-risk modifications: Upgrading existing facilities; leveraging job work network for additional capacity. - **Regulatory & Investment Status**: - Preliminary approval for additional 450 MTPM capacity increase (pending final clearance; limited to 250 MTPM under current norms). - ₹35 crore invested in new plant commissioning (Jun 2024), replacing outdated infrastructure and enabling higher output. - **Sustainability & ESG**: - 100% water recycling, ~35,000 trees on-site, green belt covering ~55% of premises. - Awarded for energy conservation (2018–2021). - Committed to global HSE standards; ISO tank fleet ensures safe transport of hazardous materials (e.g., Cl₂, SO₂, HCl).